Patent details

EP2583978 Title: Prevention and treatment of synucleinopathic and amyloidogenic disease

Basic Information

Publication number:
EP2583978
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121885628
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Prevention and treatment of synucleinopathic and amyloidogenic disease
French Title of Invention:
Prévention et traitement de maladie synucléopathique et amyloidogénique
German Title of Invention:
Verhinderung und Behandlung synukleinopathischer und amyloidogener Krankheiten
SPC Number:

Dates

Filing date:
22/02/2008
Grant date:
06/04/2016
EP Publication Date:
06/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/04/2013
EP B1 Publication Date:
06/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/02/2018
Expiration date:
22/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/02/2008
 
 

Name:
Prothena Biosciences Limited
Address:
Adelphi Plaza Upper George's Street Dun Laoghaire, Co. Dublin, Ireland (IE)

Name:
The Regents of the University of California
Address:
1111 Franklin Street, 12th Floor, Oakland, CA 94607, United States (US)

Inventor

1

Name:
Buttini Manuel, J.
Address:
United States (US)

2

Name:
Games Kate, Dora
Address:
United States (US)

3

Name:
Rockenstein Edward
Address:
United States (US)

4

Name:
Schenk Dale B.
Address:
United States (US)

5

Name:
Masliah Eliezer
Address:
United States (US)

6

Name:
Chilcote Tamie, J.
Address:
United States (US)

Priority

1

Priority Number:
697646
Priority Date:
06/04/2007
Priority Country:
United States (US)

2

Priority Number:
984721 P
Priority Date:
01/11/2007
Priority Country:
United States (US)

3

Priority Number:
710248
Priority Date:
22/02/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/18;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/02/2017
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages